- Endometrial and Cervical Cancer Treatments
- Head and Neck Cancer Studies
- Management of metastatic bone disease
- Lung Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Cervical Cancer and HPV Research
- Gastric Cancer Management and Outcomes
- Lung Cancer Research Studies
- Metastasis and carcinoma case studies
- Head and Neck Surgical Oncology
- Nonmelanoma Skin Cancer Studies
- Colorectal and Anal Carcinomas
- Glioma Diagnosis and Treatment
- Pharmaceutical studies and practices
- Prostate Cancer Treatment and Research
- CNS Lymphoma Diagnosis and Treatment
- Neuroblastoma Research and Treatments
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- Adolescent and Pediatric Healthcare
- Vascular Tumors and Angiosarcomas
- Respiratory and Cough-Related Research
- Radiopharmaceutical Chemistry and Applications
- Occupational exposure and asthma
Hacettepe University
2021-2025
Radiation Oncology Associates
2024
Manisa Celal Bayar University
2022-2024
Abstract Background Radiation Therapy Oncology Group (RTOG) and the European Organization for Research Treatment of Cancer (EORTC) recommendations are commonly used guidelines adjuvant radiotherapy in glioblastoma. In our institutional protocol, we delineate T2-FLAIR alterations as gross target volume (GTV) with reduced clinical (CTV) margins. We aimed to present oncologic outcomes compare recurrence patterns planning parameters EORTC RTOG delineation strategies. Methods Eighty-one patients...
Objective To investigate the impact of cumulative cisplatin dose on clinical outcomes in locally advanced cervical cancer patients undergoing definitive chemoradiotherapy. Methods A retrospective analysis was conducted 654 with stage IB3–IVA disease treated Radiotherapy applied as external beam pelvic or without para-aortic radiotherapy and brachytherapy. Concomitant chemotherapy form weekly 3 cisplatin. Data demographics, treatment protocols, dose, adverse effects, survival were collected....
e17534 Background: This multicentric study aimed to investigate the impact of cumulative cisplatin dose on clinical outcomes in locally advanced cervical cancer patients undergoing definitive chemoradiotherapy (CRT). Methods: A retrospective analysis was conducted 654 with stage IB3-IVA disease treated CRT. Radiotherapy (RT) applied as external beam pelvic or without para-aortic RT and brachytherapy. Concomitant chemotherapy form weekly 3-weekly cisplatin. Data demographics, treatment...
Radiation recall dermatitis (RRD) is defined as a skin reaction in the previously irradiated area triggered by systemic agent's administration. The use of immune checkpoint inhibitors (ICI) alone and combination with other treatments increasing many cancers. ICI-associated radiation reactions such dermatitis, pneumonia, myelitis have been reported so far. We report case nivolumab (anti-programmed cell death protein-1 antibody) induced RRD patient head neck cancer review publications...
To assess the rate of disease control and survival after adjuvant treatment in patients with uterine papillary serous (PSC) clear cell carcinoma (CCC) compare results between these two subtypes.The medical charts 199 de novo PSC or CCC who underwent radiotherapy (RT) following surgery 2001 2019 three radiation oncology departments were retrospectively evaluated. Adjuvant was decided by a multidisciplinary tumor board. All planned to undergo 4-6 cycles chemotherapy external beam RT (EBRT)...
<h3>Introduction/Background</h3> Cervical cancer,often diagnosed at a locally advanced stage, is typically treated with chemoradiotherapy (CRT) followed by brachytherapy (BRT). During follow-up, 14.5% of these patients experienced persistent or recurrent disease. Clear recommendations for optimal treatment in such cases are currently lacking. <h3>Methodology</h3> Patients who applied to Hacettepe University between 2015–2022, underwent cytoreductive surgery disease after primary CRT and BRT...
ABSTRACT Background This study evaluates the oncological outcomes and toxicities of indolent ocular adnexal orbital lymphomas (OOLs) treated with radiotherapy (RT) ± systemic therapy. Methods A retrospective analysis 44 patients OOLs RT was conducted. Results Most (87%) had early‐stage disease. Treatment involved alone (34%) or + therapy (66%). The median dose 30 Gy, a follow‐up 45 months. Local recurrence rates were 4% 9%, respectively. Five‐year overall disease‐free survival (DFS) 96.2%...
Aim: To evaluate the treatment results, prognostic parameters, and treatment-related toxicity in patients with Ewing sarcoma (ES)/primitive neuroectodermal tumor (PNET) of chest wall who underwent surgery, chemotherapy, radiotherapy (RT) a tertiary referral center. Methods: The data 24 under 18 years age histologic diagnosis ES/PNET that received RT our department between February 2003 July 2020 were retrospectively evaluated. was applied to primary site±whole involved whole lung metastasis....
The present study aimed to investigate the outcomes of psychiatric symptoms and family functions on treatment adherence in children, addition sociodemographic characteristics clinical factors related disease.The research sample consisted 43 children who were followed up with rheumatic heart disease diagnosis during study. Clinical features obtained from patient files. assessment device evaluating functioning strengths difficulties questionnaire scale screen emotional behavioural problems...
<h3>Introduction/Background</h3> External pelvic radiation therapy (EPRT) is recommended in stage IB grade 3 endometroid type endometrial cancer (EC) patients with substantial lymphovascular invasion (LVI), however, the role of EPRT controversial lymph node dissection (LND). The aim this study to compare and vaginal brachytherapy (VBT) terms oncological outcomes toxicity these patients. <h3>Methodology</h3> records 63 EC according FIGO 2018, who were treated between 1994–2000,...
We routinely delineate the gross tumor volume (GTV) for lymph nodes (LN) based on post-induction chemotherapy (IC) MRI in nasopharyngeal carcinoma (NPC). Herein, we investigated sufficiency of this method, particularly high-risk LNs.Eighty-one LNs with a clinical extranodal extension and/or ≥3-cm diameter 58 patients were evaluated. A new GTV covering pre-IC LN was delineated each LN.The median reduction 72.5% and 53.1% planning target volume. After 43 months, overall local control rate...